Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report.
Adam StenmanAnna KomanCatharina Ihre-LundgrenCarl Christofer JuhlinPublished in: Medicine (2021)
We conclude that the occurrence of combined BRAF and TERT promoter mutations in the primary lesion from 2016 was associated to the manifestation of distant metastases 4 years later, strengthening the benefit of mutational screening of these genes in clinical routine for thyroid carcinomas arising in aberrant locations.
Keyphrases
- dna methylation
- wild type
- lymph node
- transcription factor
- genome wide
- gene expression
- metastatic colorectal cancer
- squamous cell carcinoma
- single cell
- rare case
- small cell lung cancer
- lymph node metastasis
- risk assessment
- sars cov
- cell therapy
- clinical practice
- high grade
- stem cells
- bioinformatics analysis
- mesenchymal stem cells